您的位置:首页 > 产品中心 > 522-48-5, Tetrahydrozoline hydrochloride
Tetrahydrozoline hydrochloride
产品价格查看更多规格...
产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
3250742 | 1 G | 1037 | |||
3250742 | 10 G | 5200 |
产品别名
522-48-5
Tetrahydrozoline hydrochloride
Tetryzoline hydrochloride
4,5-Dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-1H-imidazole monohydrochloride
结构式
基本信息
Empirical Formula【经验(实验)分子式】 | C13H16N2 · HCl |
Molecular weight | 236.74 |
EC number【EC 号】 | 208-329-3 |
MDL number | MFCD00058029 |
PubChem Substance ID【PubChem化学物质编号】 | 24278736 |
NACRES | NA.77 |
Biochem/physiol Actions【生化/生理作用】 | Tetrahydrozoline is an α-adrenergic agonist and an imidazoline derivative. It plays a crucial role in the constriction of conjunctival blood vessels. Tetrahydrozoline is a common component of nasal and eye drop formulations. |
Features and Benefits【特点和优势】 | This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. |
产品性质
Quality Level【质量水平】 | 200 |
Assay【测定】 | ≥98% (HPLC) |
solubility【溶解性】 | H2O: freely soluble alcohol: freely soluble chloroform: very slightly soluble diethyl ether: insoluble |
originator【创始人】 | Novartis |
SMILES string | Cl.C1CC(C2=NCCN2)c3ccccc3C1 |
InChI | 1S/C13H16N2.ClH/c1-2-6-11-10(4-1)5-3-7-12(11)13-14-8-9-15-13;/h1-2,4,6,12H,3,5,7-9H2,(H,14,15);1H |
InChI key | BJORNXNYWNIWEY-UHFFFAOYSA-N |
Gene Information | human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152) |
packaging【包装】 | 1, 10 g in poly bottle |
安全信息
Pictograms【象形图】 | GHS07 |
Signal word【警示用语:】 | Warning |
Hazard Statements | H302 - H315 - H319 - H335 |
Precautionary Statements | P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338 |
Hazard Classifications【危险分类】 | Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
Target Organs【靶器官】 | Respiratory system |
Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
WGK | WGK 3 |
Personal Protective Equipment【个人防护装备】 | dust mask type N95 (US), Eyeshields, Gloves |